Document is current
Any future updates will be listed below
-
Authors
Farooq, Asim V.
Kaur, Savreet
Hundal, Pradeep
Burke, Maureen
Sulaiman, Rosilin
Zahlten-Kümeli, Anita
Raoof, Sumera
Li, Zhezhen
Murias Dos Santos, Telma
Huang, Xiaojun Jacqueline
Colby, Kathryn
- License Information
-
More Information
Article History
Received: 21 February 2025
Accepted: 26 March 2025
First Online: 12 May 2025
Declarations
:
: Asim V. Farooq: Ambrx, Amgen, Eisai, GlaxoSmithKline, Mythic Therapeutics, Sanofi, Seagen/Pfizer, Skye Bioscience (consultant), AstraZeneca (member of data monitoring committee); Savreet Kaur: Amgen (employee and stockholder); Pradeep Hundal: Amgen (employee); Maureen Burke: Amgen (employee and stockholder), Arcus Biosciences, Astex Pharmaceuticals, Taiho Oncology (past employment); Rosilin Sulaiman: Amgen (employee); Anita Zahlten-Kuemeli: Amgen (employee and stockholder); Sumera Raoof: Amgen (employee and stockholder); Zhezhen Li: Amgen (employee and stockholder); Telma Murias Dos Santos: Amgen (employee and stockholder); Xiaojun Huang: Amgen (employee and stockholder); Kathryn Colby: Amgen (consultant).
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
